Nurturing early-stage and emerging life science companies
BioSp Logo
line
Event Writeup
Basic Intellectual Property Strategy for Early Stage Bi...
Read Write-up

Networking to the Next Degree
Read Write-up

News
BioStrategy Partners Featured in Philadelphia Business Journal Supplement
Late last year, the Pennsylvania Biotechnology Association received a call from ...
Read More

TIMOTHY J. PELURA, Ph.D.

photo

Dr. Pelura is a serial life science entrepreneur with over 35 years of experience in the pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas. Currently, Dr. Pelura is President and CEO of Immunome, a start-up biopharmaceutical company developing therapeutic native human monoclonal antibodies. Immunome has license to a powerful platform technology which mines the pool of antibodies naturally produced as a direct result of immunization or exposure to disease. The company is developing drug candidates for the treatment of serious infectious diseases.

Previously, Dr. Pelura was founding President and CEO of Promedior, a product-focused biotech company developing novel therapeutics for the treatment of fibrotic disorders and diseases. This technology was licensed out of a major university as a raw technology. In less than 3 years, he attracted $30MM in tier 1 venture capital, established the corporate strategy, built the management team and brought this nascent technology to the clinic. Prior to Promedior, Dr. Pelura served as Chief Scientific Officer for Kereos, responsible for all R&D activities for their oncology, cardiology, and molecular imaging programs. Prior to joining Kereos, he served as President and COO of Provasis Therapeutics, a developer of interventional neurosurgical devices and was successful in selling the company to the largest medical device company in the world with significant returns for the investors. Dr. Pelura held executive R&D positions at Neuron Therapeutics and Alliance Pharmaceutical Corp. At both companies he was pivotal in the development and commercialization of numerous innovative medical products. Earlier, Dr. Pelura worked in various capacities at KabiVitrum and Pharmacia where he was involved with parenteral nutrition, drug delivery, and lipid emulsion research and development.

Dr. Pelura, an avid believer in the tremendous potential of the tri-state region, is pivotally involved in several non-profit, regional life science development initiatives. Dr. Pelura holds a Ph.D. in chemistry from Rutgers University.

 

BioSP logo screen
line